FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132023194> ?p ?o ?g. }

• W3132023194 endingPage "1048" @default.
• W3132023194 startingPage "1044" @default.
• W3132023194 abstract "Background Thromboembolic complications (TECs) are frequent during the endovascular treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin and clopidogrel is recommended for the perioperative period. In patients with a poor response, clopidogrel is a risk factor for TECs. To prevent TECs, our study assessed the stratified use of prasugrel. Methods Patients who underwent endovascular therapy for unruptured cerebral aneurysms from April 2017 to August 2019 were enrolled in this clinical study and given premedication with aspirin and clopidogrel for 2 weeks prior to the procedure. P2Y12 reaction units (PRU) were measured using the VerifyNow assay on the day before the procedure (tailored group). In subgroups with PRU <240, the clopidogrel dose was maintained (CPG subgroup). In subgroups with PRU ≥240, clopidogrel was changed to prasugrel (PSG subgroup). We compared the occurrence of TECs with retrospective consecutive cases from January 2015 to March 2017 without PRU assessments (non-tailored group). The frequency of TECs within 30 days was assessed as the primary endpoint. Results The tailored and non-tailored groups comprised 167 and 50 patients, respectively. TECs occurred in 11 (6.6%) and 8 (16%) patients in the tailored and non-tailored groups (P=0.048), respectively. The HR for TECs was significantly reduced in the tailored group (HR 0.3, 95% CI 0.11 to 0.81); P=0.017) compared with the non-tailored group. Conclusion The results suggest that tailored dual antiplatelet therapy medication with PRU significantly reduces the frequency of TECs without increasing hemorrhagic complications." @default.
• W3132023194 created "2021-03-01" @default.
• W3132023194 creator A5001015536 @default.
• W3132023194 creator A5004664509 @default.
• W3132023194 creator A5014654359 @default.
• W3132023194 creator A5019217784 @default.
• W3132023194 creator A5021205825 @default.
• W3132023194 creator A5021341455 @default.
• W3132023194 creator A5023721647 @default.
• W3132023194 creator A5029152750 @default.
• W3132023194 creator A5033516051 @default.
• W3132023194 creator A5035046147 @default.
• W3132023194 creator A5041765058 @default.
• W3132023194 creator A5042777000 @default.
• W3132023194 creator A5044595331 @default.
• W3132023194 creator A5053042807 @default.
• W3132023194 creator A5054234667 @default.
• W3132023194 creator A5064857129 @default.
• W3132023194 creator A5070028672 @default.
• W3132023194 creator A5072680254 @default.
• W3132023194 creator A5084124092 @default.
• W3132023194 date "2021-02-25" @default.
• W3132023194 modified "2023-10-16" @default.
• W3132023194 title "Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel" @default.
• W3132023194 cites W1535785785 @default.
• W3132023194 cites W1860205706 @default.
• W3132023194 cites W1923386888 @default.
• W3132023194 cites W1958005423 @default.
• W3132023194 cites W1985059672 @default.
• W3132023194 cites W2018856451 @default.
• W3132023194 cites W2074157955 @default.
• W3132023194 cites W2115774068 @default.
• W3132023194 cites W2122617197 @default.
• W3132023194 cites W2125657030 @default.
• W3132023194 cites W2146453185 @default.
• W3132023194 cites W2156212436 @default.
• W3132023194 cites W2161785946 @default.
• W3132023194 cites W2172295140 @default.
• W3132023194 cites W2329455047 @default.
• W3132023194 cites W2461238496 @default.
• W3132023194 cites W2515922986 @default.
• W3132023194 cites W2535565427 @default.
• W3132023194 cites W2743173943 @default.
• W3132023194 cites W2768439742 @default.
• W3132023194 cites W2781203827 @default.
• W3132023194 cites W2885378974 @default.
• W3132023194 cites W2886132392 @default.
• W3132023194 cites W2888066605 @default.
• W3132023194 cites W2909586339 @default.
• W3132023194 cites W2922306330 @default.
• W3132023194 cites W2955792544 @default.
• W3132023194 cites W298666372 @default.
• W3132023194 cites W2989714602 @default.
• W3132023194 cites W3012340745 @default.
• W3132023194 doi "https://doi.org/10.1136/neurintsurg-2020-016994" @default.
• W3132023194 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8526880" @default.
• W3132023194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33632886" @default.
• W3132023194 hasPublicationYear "2021" @default.
• W3132023194 type Work @default.
• W3132023194 sameAs 3132023194 @default.
• W3132023194 citedByCount "14" @default.
• W3132023194 countsByYear W31320231942021 @default.
• W3132023194 countsByYear W31320231942022 @default.
• W3132023194 countsByYear W31320231942023 @default.
• W3132023194 crossrefType "journal-article" @default.
• W3132023194 hasAuthorship W3132023194A5001015536 @default.
• W3132023194 hasAuthorship W3132023194A5004664509 @default.
• W3132023194 hasAuthorship W3132023194A5014654359 @default.
• W3132023194 hasAuthorship W3132023194A5019217784 @default.
• W3132023194 hasAuthorship W3132023194A5021205825 @default.
• W3132023194 hasAuthorship W3132023194A5021341455 @default.
• W3132023194 hasAuthorship W3132023194A5023721647 @default.
• W3132023194 hasAuthorship W3132023194A5029152750 @default.
• W3132023194 hasAuthorship W3132023194A5033516051 @default.
• W3132023194 hasAuthorship W3132023194A5035046147 @default.
• W3132023194 hasAuthorship W3132023194A5041765058 @default.
• W3132023194 hasAuthorship W3132023194A5042777000 @default.
• W3132023194 hasAuthorship W3132023194A5044595331 @default.
• W3132023194 hasAuthorship W3132023194A5053042807 @default.
• W3132023194 hasAuthorship W3132023194A5054234667 @default.
• W3132023194 hasAuthorship W3132023194A5064857129 @default.
• W3132023194 hasAuthorship W3132023194A5070028672 @default.
• W3132023194 hasAuthorship W3132023194A5072680254 @default.
• W3132023194 hasAuthorship W3132023194A5084124092 @default.
• W3132023194 hasBestOaLocation W31320231941 @default.
• W3132023194 hasConcept C126322002 @default.
• W3132023194 hasConcept C2777028646 @default.
• W3132023194 hasConcept C2777628954 @default.
• W3132023194 hasConcept C2777849778 @default.
• W3132023194 hasConcept C2781413609 @default.
• W3132023194 hasConcept C31174226 @default.
• W3132023194 hasConcept C42219234 @default.
• W3132023194 hasConcept C49059817 @default.
• W3132023194 hasConcept C71924100 @default.
• W3132023194 hasConceptScore W3132023194C126322002 @default.
• W3132023194 hasConceptScore W3132023194C2777028646 @default.
• W3132023194 hasConceptScore W3132023194C2777628954 @default.
• W3132023194 hasConceptScore W3132023194C2777849778 @default.

• next